Our study demonstrates that chronic ATRA treatment upregulates hypothalamic RARα and CRH, key regulators of the hypothalamic–pituitary–adrenal (HPA) axis, leading to depression-like behaviors in rats. Here, RARA is linked to depressive disorder.